Immune System

Haschek and Rousseaux's Handbook of Toxicologic Pathology

Volumn , Issue , 2013, Pages 1795-1862

  Kuper, C Frieke ^a   Ruehl Fehlert, Christine ^b   Elmore, Susan A ^c   Parker, George A ^d  

^a TNO   (Netherlands)

^b BAYER PHARMA AG   (Germany)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d WIL Research   (United States)

Author keywords

Allergy; Autoimmune disease; Hypersensitivity; Leukemia; Lymphoid depletion; Lymphoid proliferation; Lymphoma; Mucosa associated lymphoid tissue (MALT); Neuroendocrine network

Indexed keywords

EID: 84884074053     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-415759-0.00049-2     Document Type: Chapter

References (81)

1. A Monograph on Histomorphologic Evaluation of Lymphoid Organs Toxicol. Pathol. 2006, 34(Number 5).
2. Lawrence D.A. Toxicology of the Immune System. Vol. 5 of Comprehensive Toxicology series 2010, Pergamon, Cambridge, UK. second ed.
3. Vohr H.-W. Encyclopedic Reference of Immuno-toxicology 2005, Springer, Berlin, Germany.
4. WHO/IPCS Monograph Principles and Methods for Assessing Direct Immunotoxicity Associated with Exposure to Chemicals. Environmental Health Criteria 180 1996, WHO, Geneva, Switzerland.
5. Monograph W.H.O./I.P.C.S. Principles and Methods for Assessing Autoimmunity Associated with Exposure to Chemicals. Environmental Health Criteria 236 2006, WHO, Geneva, Switzerland.
6. Abo T. Extrathymic pathways of T-cell differentiation: a primitive and fundamental immune system. Microbiol. Immunol. 1993, 37:247-258.
7. Brandtzaeg P., Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 2004, 25:570-575.
8. Correa S.G., Maccioni M., Rivero V.E., Iribarren P., Sotomayor, C.E., Riera C.M. Cytokines and the immune-neuroendocrine network: What did we learn from infection and autoimmunity?. Cytokin. Growth Factor Rev. 2007, 18:125-134.
9. Haley P. Interspecies differences in the structure and function of the immune system. Toxicology 2003, 188:49-71.
10. Hameleers D.M., Van der Ven I., Sminia T., Biewenga J. Anti-TNP-forming cells in rats after different routes of priming with TNP-LPS followed by intranasal boosting with the same antigen. Res. Immunol. 1990, 141:515-528.
11. Kendall M.D., Clarke A.G. The thymus in the mouse changes its activity during pregnancy: a study of the microenvironment. J. Anat 2000, 197:393-411.
12. Koornstra P.J., De Jong F.I.C.R.S., Vlek L.M.K., Marres E.H.M.A., Van Breda Vriesman P.J.C. The Waldeyer ring equivalent in the rat. Acta Otolaryngol. 1991, 111:591-599.
13. Kuper C.F., Koornstra P.J., Hameleers D.M.H., Biewenga J., Spit B.J., Duijvestijn A.M., Van Breda Vriesman P.J.C., Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol Today 1992, 13:219-224.
14. Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. 2005, 5:606-616.
15. Menke A., Wolterbeek A., Snel C., Bruijntjes J., de Groot D., van Oostrum L., Waalkens I., Kuper C.F. Potentially increased sensitivity of pregnant and lactation female rats to immunotoxic agents. Toxicol. Pathol. 2012, 40:255-260.
16. Mohr U., Dungworth D.L., Capen C.C. Pathobiology of the Aging Rat 1992, ILSI Press, Washington, DC, vol. I.
17. Mohr U., Dungworth D.L., Capen C.C. Pathobiology of the Aging Mouse 1996, ILSI Press, Washington, DC, vol. I.
18. Ohteki T., Okuyama R., Seki S., Abo T., Sugiura K., Kusumi A., Ohmori T., Watanabe H., Kumagai K. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J. Immunol. 1992, 149:1562-1570.
19. Pabst R. Plasticity and heterogeneity of lymphoid organs: What are the criteria to call a lymphoid organ primary, secondary or tertiary?. Immunol. Lett. 2007, 112:1-8.
20. Penninks A.H., van Mierlo G.J.D., Kuper F., Snel C.J., Ganderup N.-C., Wolterbeek A.P.M. Juvenile immuno-development in minipigs. Pediatric Nonclinical Drug Testing: Principles, Requirements, and Practices 2012, 231-254. John Wiley & Sons, Hoboken, NJ. A.M. Hoberman, E.M. Lewis (Eds.).
21. Ploemen J.-P., Ravesloot W.T.M., Van Esch E. The incidence of thymic B lymphoid follicles in healthy beagle dogs. Toxicol. Pathol. 2003, 31:214-219.
22. Pond C.M. Adipose tissue and the immune system. Prostagl., Leukotr. Ess. Fatty Acids 2005, 73:17-30.
23. Sainte-Marie G., Peng F.S., Belisle C. Overall architecture and pattern of lymph flow in the rat lymph node. Am. J. Anat 1982, 164:275-309.
24. Singh P., Coskun Z.Z., Goode C., Dean A., Thompson-Snipes L., Darlington G. Lymphoid neogenesis and immune infiltration in aged liver. Hepatology 2008, 47:1680-1690.
25. Tilney N.L. Patterns of lymphatic drainage in the adult laboratory rat. J. Anat. 1971, 109:369-383.
26. Van den Broeck W., Derore A., Simoens P. Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J. Immunol. Methods 2006, 312:12-19.
27. Van de Pavert S.A., Mebius R.E. New insights into the development of lymphoid tissues. Nat. Rev. Immunol 2010, 10:664-674.
28. Zoller A.L., Schnell F.J., Kersh G.J. Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration. Immunology 2007, 1121:207-215.
29. Batista-Duharta A., Lindblad E.B., Oviedo-Orta E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol. Lett. 2011, 203:97-105.
30. Bhogal N. Immunotoxicity and immunogenicity of biopharmaceuticals: Design concepts and safety assessment. Curr. Drug Saf. 2010, 5:293-307.
31. Brayton C.F., Treuting P.M., Ward J.M. Pathobiology of aging mice and GEM: Background strains and experimental design. Vet. Pathol. 2012, 49:85-105.
32. Brennan F.R., Morton L.D., Spindeldreher S., Kiessling A., Allenspach R., Hey A., Muller P.Y., Frings W., Sims J. Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies. mAbs. 2010, 2:233-255.
33. Collinge M., Burns-Naas L.A., Chellman G.D., Kawabata T.T., Komocsar W.J., Piccottio J.R., Shenton J., Wierda D. Developmental immunotoxicity (DIT) testing of pharmaceuticals: Current practices, state of the science, knowledge gaps, and recommendations. J. Immunotoxicol. 2012, 9:210-230.
34. Duramad P., Holland N.T. Biomarkers of immunotoxicity for environmental and public health research. Int. J. Environ. Res. Public Health 2011, 8:1388-1401.
35. Elmore S.A. Enhanced histopathology of the immune system: A review and update. Toxicol. Pathol. 2012, 40:148-156.
36. Germolec D.R., Nyska A., Kashon M., Kuper C.F., Kommineni C., Johnson K.A., Luster M.I. Extended histopathology in immunotoxicity testing: interlaboratory validation studies. Toxicol. Sci. 2004, 78:107-115.
37. Haley P. Histomorphology of the immune system: Basic steps in assessing immunotoxicity. Chapter 2.2. Immunotoxicology Strategies for Pharmaceutical Safety Assessment 2008, 27-44. John Wiley & Sons Inc, Hoboken, NJ. D. Herzyk, J.L. Bussiere (Eds.).
38. Haley P., Perry R., Ennulat D., Frame S., Johnson C., Lapointe J.-M., Nyska A., Snyder P.W., Walker D., Walker G. Best practice guidelines for the routine pathology evaluation of the immune system (STP). Toxicol. Pathol. 2005, 33:404-407.
39. Harleman J. The immune system - multiple sites but one system. Exp. Toxicol. Pathol 2006, 57. 359-261.
40. Kuper C.F., Harleman H., Richther-Reichhelm H., Vos J.G. Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol. Pathol. 2000, 28:454-466.
41. Landreth K.S. Critical windows in development of the rodent immune system. Hum. Exp. Toxicol. 2002, 21:493-498.
42. Leifer C.A., Dietert R.R. Early life environment and developmental immunotoxicity in inflammatory dysfunction and disease. Toxicol. Environm. Chem. 2011, 93:1463-1485.
43. Linton P.J., Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol. 2004, 5:133-139.
44. Lloberas J., Celada A. Effect of aging on macrophage function. Exp. Gerontol. 2002, 37:1325-1331.
45. Norris S., Collins C., Doherty D.G., Smith F., McEntee G., Traynor O., Nolan N., Hegarty J., O'Farrelly C. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 1998, 28:84-90.
46. Parker G.A., Picut C.A. Immune functioning in non- lymphoid organs: The liver. Toxicol. Pathol. 2012, 40:237-247.
47. Pruett S.B., Fan R., Zhang Q., Schwab C. Patterns of immunotoxicity associated with chronic as compared with acute exposure to chemical or physical stressors and their relevance to the role of stress with regard to immunotoxicity testing. Toxicol. Sci. 2009, 109:265-275.
48. Randall K.J., Pearse G. A dual labeling technique for the immunohistochemical demonstration of T-lymphocyte subsets in formalin-fixed, paraffin-embedded rat lymphoid tissue. Toxicol. Pathol. 2008, 36:795-804.
49. Rehg J.E., Bush D., Ward J.M. The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissues and interpretation of proliferative and inflammatory lesions of mice and rats. Toxicol. Pathol. 2012, 40:345-374.
50. Ruehl-Fehlert C., Bradley A., George C., Germann P.G., Bolliger A.P., Schulte A. Harmonization of immunotoxicity guidelines in the ICH process (ESTP). Exp. Toxicol. Pathol. 2005, 57:1-5.
51. Shaw A.C., Joshi S., Greenwood H., Panda A., Lord J.M. Aging of the innate immune system. Curr. Opin. Immunol. 2010, 22:507-513.
52. Weinstock D., Lewis D.B., Parker G.A., Beyer J., Collinge M., Brown T.P., Dybdal N. Toxicopathology of the developing immune system: investigative and development strategies. Toxicol. Pathol. 2010, 38:1111-1117.
53. Benavides F., Gomez G., Venables-Griffith A., Lambertz I., Flores M., Angel J.M., Fuchs-Young R., Richie E., Conti C.J. Differential susceptibility to chemically induced thymic lymphomas in SENCARB and SSIN inbred mice. Mol. Carcinog. 2006, 45:543-548.
54. Bruder M.C., Spanhaak S., Bruijntjes J.P., Michielsen C.P.P.C., Vos J.G., Kuper C.F. Intestinal T lymphocytes of different rat strains in immunotoxicity. Toxicol. Pathol. 1999, 27:171-179.
55. EMEA ICH Topic S8 Immunotoxicity studies for human pharmaceuticals 2006, EMEA/CHMP//167235/2004-ICH.
56. Everds N.E., Snyder P.W., Rosol T.J., Creasy D.M., Bailey K.L., Bolon B., Foley G.L., Sellers T. Stress during routine nonclinical safety studies: A review of its impact and assessment. Toxicol. Pathol. 2012, (in press).
57. Finch G.L., Hoover M.D., Hahn F.F., Nikula K.J., Belinsky S.A., Haley P.J., Griffith W.C. Animal models of beryllium-induced lung disease. Environ. Health Persp. 1996, 104:973-979.
58. Fletcher A.L., Lowen T.E., Sakkal S., Reiseger J.J., Hammett M.V., Seach N., Scott H.S., Boyd R.L., Chidgey A.P. Ablation and regeneration of tolerance-inducing medullary thymic epithelial cells after cyclosporine, cyclophosphamide, and dexamethasone treatment. J. Immunol 2009, 183:823-831.
59. Fort M.M., Narayanan P.K. Manipulation of regulatory T-cell function by immunomodulators. A boon or a curse?. Toxicol. Sci. 2010, 117:253-262.
60. Frith C.H., Ward J.M., Harleman J.H., Stromberg S., Halm S., Inue T., Wright J.A. Hematopoietic System. International classification of rodent tumors. The mouse 2001, 417-451. Springer Verlag, Berlin. U. Mohr, C.C. Capen, D.L. Dungworth, et al (Eds.).
61. Gopinath C., Prentice D.E., Lewis D.J. The lymphoid system. Atlas of Experimental Pathology. Current Histopathology 1987, vol. 13:122-137. MTP Press Limited, Lancaster, UK.
62. Hailey J.R., Harleman J.H., Stromberg P., Ward J.M. Hematopoietic System. International classification of rodent tumors 1993, 1-27. Part 1, the rat. Fascicle 4. IARC Scientific No. 122, Lyon. U. Mohr, C.C. Capen, D.L. Dungworth et al, et al (Eds.).
63. Ham M.F., Ko Y.-H. Natural killer cell neoplasm: biology and pathology. Int. J. Hematol. 2010, 92:681-689.
64. Hial H. Genetic predisposition to lymphomas in mice. Pathol. Int. 1996, 46:707-718.
65. Hutto D.L. Opportunistic infections in non-human primates exposed to immunomodulatory biotherapeutics: considerations and case examples. J. Immunotoxicol. 2010, 7:120-127.
66. Report of validation study of assessment of direct immunotoxicity in the rat. International Collaborative Immunotoxicity Study. Toxicology 1998, 125:183-201. ICISIS group investigators.
67. Kammueller M.E., Bloksma N., Seinen W. Autoimmunity and Toxicology. Immune Disregulation Induced by Drugs and Chemicals 1989, Elsevier Science, Amsterdam, pp. 3-34.
68. Kuper C.F., Van Zijverden M., Klaassen C., Tegelenbosch-Schouten M., Wolterbeek A.P.M. Effects of cyclosporin A and cyclophosphamide on Peyer's patches in rat exposed in utero and neonatally or during adult age. Toxicol. Pathol 2007, 35:226-232.
69. Lyons A.B., Watkins M., Simpson C.C., Muller H.K. Modulation of lymphocyte migration to the murine spleen after marginal zone macrophage phagocytosis of blood-borne particulate material. Immunol. Invest 2006, 35:75-92.
70. Ogiu T., Sakura Y., Maekawa A. Sequential observations of thymic lymphoma development induced in 10-week-old F344 rats by N-propyl-N-nitrosurea. Acta Pathol. Jpn. 1985, 35:1191-1200.
71. Pichler W.J., Naisbitt D.J., Park B.K. Immune pathomechanism of drug hypersensitivity reactions. J. Allergy. Clin. Immunol. 2011, 127:S74-S81.
72. Pinon-Zarate G., Rodriguez-Lara V., Rojas-Lemus M., Martinez-Pedraza M., Gonzalez-Villalva A., Mussali-Galante P., Fortoul T.I., Barquet A., Masso F., Montano L.F. Vanadium pentoxide inhalation provokes germinal center hyperplasia and suppressed humoral immune responses. J. Immunotoxicol 2008, 5:115-122.
73. Qazi M.R., Xia Z., Bogdanska J., Chang S.C., Ehresman D.J., Butenhoff J.L., Nelson B.D., De Pierre J.W., Abedi-Valugerdi M. The atrophy and changes in the cellular compositions of thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part bay peroxisome-proliferator activated receptor-alpha (PPARalpha). Toxicology 2009, 260:68-76.
74. Qi C.-F., Zhou J.X., Lee C.H., Naghashfar Z., Xiang S., Kovalchuk A.L., Fredrickson T.N., Hartley J.W., Roopenian D.C., Davidson W.F., Janz S., Morse H.C. Anaplastic, plasmablastic and plasmacytic plasmacytomas of mice; relationships to human plasma cell neoplasms and late stage differentiation of normal B-cells. Cancer Res. 2007, 67:2439-2447.
75. Schulte A., Althoff J., Ewe S., Richter-Reichhelm H.B., Group Investigators B.G.V.V. Two immunotoxicity ring studies according to OECD TG 407-comparison of data on cyclosporin A and hexachlorobenzene. Regul. Toxicol. Pharmacol. 2002, 36:12-21.
76. Son W.-C., Bell D., Taylor I., Mowat V. Profile of early occurring spontaneous tumors in Han Wistar rats. Toxicol. Pathol. 2010, 38:292-296.
77. Uddin M.N., Nishio N., Ito S., Suzuki H., Isobe K. Toxic effects of D-galactose on thymus and spleen that resemble aging. J. Immunotoxicol. 2010, 7:165-173.
78. Wang Y., Wang L., Liang L., Qiu W., Zhang J., Zhou Q., Jiang G. Modulation of dietary fat on the toxicological effects in thymus and spleen in BALB/c mice exposed to perfluorooctane sulfonate. Toxicol. Lett. 2011, 204:174-182.
79. Ward J.M. Lymphomas and leukemias in mice. Exp. Toxicol. Pathol. 2006, 57:477-481.
80. Wehner N.G., Gasper C., Shopp C., Nelson J., Draper K., Parker S., Clarke J. Immunotoxicity profile of natalizumab. J. Immunotoxicol. 2009, 6:115-129.
81. Ward J.M., Rehg J.E., Morse H.C. Differentiation of rodent immune and hematopoietic system reactive lesions from hyperplasias. Toxicol. Pathol. 2012, 40:425-434.